Worth Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Worth Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.13M	Buy	13,431 +9,946	+285%	+$1.34M	0.68%	26
2026 Q1	$445K	Sell	3,485 -23,187	-87%	-$2.89M	0.17%	115
2025 Q4	$3.25M	Buy	26,672 +22,407	+525%	+$2.57M	1.38%	15
2025 Q3	$427K	Buy	+4,265	New	+$384K	0.19%	85
2024 Q4	–	Sell	-4,451	Closed	-$440K	–	171
2024 Q3	$440K	Sell	4,451 -11,788	-73%	-$1.16M	0.24%	79
2024 Q2	$1.51M	Buy	16,239 +3,658	+29%	+$328K	0.89%	31
2024 Q1	$1.19M	Buy	+12,581	New	+$1.17M	0.73%	32
2023 Q1	–	Sell	-240	Closed	-$19.9K	–	541
2022 Q4	$19.9K	Buy	+240	New	+$19.4K	0.01%	260

Other funds holding XBI

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

PSP Research Newtown Square, Pennsylvania $188M AUM

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

WAM

Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return

RFM

Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return

NHFG

New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return

MFS

Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return

LRPA

L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return

SGH

Sivik Global Healthcare Greenwich, Connecticut $132M AUM 24.1% 1-Year Est. Return

EWM

Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

Worth Asset Management's XBI Position: Q2 2026 in Review

Worth Asset Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 285% in Q2 2026, buying an estimated $1.34M and bringing the position to 13,431 shares worth $2.13M. The position accounts for 0.68% of the portfolio, ranked #26.

Worth Asset Management first reported a position in XBI in Q4 2022 and has held it in 8 quarters since. The position peaked at $3.25M in Q4 2025. 225 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Worth Asset Management held 13,431 shares of State Street SPDR S&P Biotech ETF worth $2.13M as of Q2 2026.
Worth Asset Management bought 9,946 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $1.34M.
State Street SPDR S&P Biotech ETF made up 0.68% of Worth Asset Management's portfolio in Q2 2026, its #26 holding.
Worth Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and has held it in 8 quarters since.
Worth Asset Management's State Street SPDR S&P Biotech ETF position peaked at $3.25M in Q4 2025.
225 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Worth Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.